|
GB191115253A
(en)
|
1911-06-30 |
1912-06-20 |
Adolph Schneider |
Improvements in Bottle-filling Machines.
|
|
US2382696A
(en)
|
1939-04-01 |
1945-08-14 |
Milleville Marie Joseph Mau De |
Method and apparatus for filling containers
|
|
GB684057A
(en)
|
1949-11-30 |
1952-12-10 |
Stockholms Bryggerier Ab |
Machine of the rotatory table type for the treatment of bottles and the like containers
|
|
US2699718A
(en)
|
1952-04-10 |
1955-01-18 |
Francis X Wright |
Filling apparatus with beverage preparation mechanism
|
|
FR1418965A
(fr)
|
1964-10-14 |
1965-11-26 |
Chelle Ets |
Tireuse de liquides à double utilisation
|
|
AU554222B2
(en)
|
1981-10-13 |
1986-08-14 |
Toyo Garasu K.K. |
Inspecting glass containers
|
|
ES2099718T3
(es)
|
1990-07-02 |
1997-06-01 |
Hoechst Ag |
Analogos de oligonucleotidos con uniones internucleotidicas de 3'-3' o 5'-5' terminales.
|
|
WO1995006731A2
(en)
|
1993-09-02 |
1995-03-09 |
Ribozyme Pharmaceuticals, Inc. |
Non-nucleotide containing enzymatic nucleic acid
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US20030050263A1
(en)
|
1994-07-15 |
2003-03-13 |
The University Of Iowa Research Foundation |
Methods and products for treating HIV infection
|
|
FR2732971B1
(fr)
|
1995-04-13 |
1997-07-04 |
Genset Sa |
Oligonucleotide sens inhibiteur de virus herpes simplex (hsv) a structure en haltere
|
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
|
AU738170B2
(en)
|
1996-10-16 |
2001-09-13 |
Icn Pharmaceuticals, Inc. |
Monocyclic L-nucleosides, analogs and uses thereof
|
|
DE19648625A1
(de)
|
1996-11-13 |
1998-05-14 |
Soft Gene Gmbh |
Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6251666B1
(en)
|
1997-03-31 |
2001-06-26 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid catalysts comprising L-nucleotide analogs
|
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
US6192481B1
(en)
|
1998-08-18 |
2001-02-20 |
International Business Machines Corporation |
Structure and method for power sequencing of disk drives in a computer system
|
|
JP4812942B2
(ja)
|
1999-02-26 |
2011-11-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6737066B1
(en)
|
1999-05-06 |
2004-05-18 |
The Immune Response Corporation |
HIV immunogenic compositions and methods
|
|
WO2001000232A2
(en)
|
1999-06-29 |
2001-01-04 |
Smithkline Beecham Biologicals S.A. |
Use of cpg as an adjuvant for hiv vaccine
|
|
DE19935756A1
(de)
*
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
|
WO2001040515A1
(en)
|
1999-11-12 |
2001-06-07 |
Isis Pharmaceuticals, Inc. |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
|
|
ATE384072T1
(de)
|
2000-09-26 |
2008-02-15 |
Idera Pharmaceuticals Inc |
Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
|
|
WO2002060476A2
(de)
|
2001-01-31 |
2002-08-08 |
Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh |
Tumorvakzine
|
|
JP2005504020A
(ja)
|
2001-07-03 |
2005-02-10 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
ヌクレアーゼ耐性キメラオリゴヌクレオチド
|
|
ES2254758T3
(es)
|
2001-10-02 |
2006-06-16 |
Mologen Ag |
Medicamento para mejorar la respuesta inmunitaria.
|
|
PT1432805E
(pt)
|
2001-10-02 |
2005-10-31 |
Mologen Ag |
Estrutura de expressao do dna para tratamento de infeccoes de leishmaniose
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
JP2003204793A
(ja)
|
2002-01-15 |
2003-07-22 |
Takeda Chem Ind Ltd |
ウイルス性疾患の予防または治療剤
|
|
DE10211558A1
(de)
|
2002-03-15 |
2003-10-09 |
Noxxon Pharma Ag |
Neue Formen RNAi
|
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
AU2003287332A1
(en)
|
2002-11-01 |
2004-06-07 |
The Regents Of The University Of California |
Methods of treating pulmonary fibrotic disorders
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
US7501503B2
(en)
|
2002-12-31 |
2009-03-10 |
Mcgill University |
Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase
|
|
RU2351362C2
(ru)
|
2003-03-26 |
2009-04-10 |
Цитос Байотекнолоджи Аг |
КОНЪЮГАТЫ ПЕПТИДА Melan-A, АНАЛОГА ВИРУСОПОДОБНОЙ ЧАСТИЦЫ
|
|
WO2004111247A1
(de)
|
2003-06-10 |
2004-12-23 |
Mologen Ag |
Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
|
|
CN101454451A
(zh)
|
2003-10-30 |
2009-06-10 |
科勒制药有限公司 |
具有增强免疫刺激能力的c类寡核苷酸类似物
|
|
WO2005056020A2
(en)
|
2003-12-02 |
2005-06-23 |
Corgentech, Inc. |
Nf-kb oligonucleotide decoy molecules
|
|
CN102994515A
(zh)
|
2003-12-30 |
2013-03-27 |
莫洛根股份公司 |
同种异基因肿瘤治疗剂
|
|
DK1716234T3
(da)
|
2004-02-20 |
2014-01-20 |
Mologen Ag |
Substitueret, ikke-kodende nukleinsyremolekyle til terapeutisk og profylaktisk immunstimulering i mennesker og højerestående dyr
|
|
JP3976742B2
(ja)
|
2004-02-27 |
2007-09-19 |
江守商事株式会社 |
インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド
|
|
EP1749096B1
(de)
|
2004-05-28 |
2013-07-17 |
Mologen AG |
Herstellungsverfahren geeigneter dna-konstrukte zur spezifischen hemmung der genexpression durch rna-interferenz
|
|
EE200700003A
(et)
|
2004-06-15 |
2007-06-15 |
Idera Pharmaceuticals, Inc. |
Immunostimuleeriv oligonukleotiid ning selle kasutamine
|
|
WO2006015560A1
(de)
|
2004-08-09 |
2006-02-16 |
Mologen Ag |
Immunmodulierendes mittel in verbindung mit chemotherapeutischen massnahmen
|
|
US7879992B2
(en)
|
2005-01-31 |
2011-02-01 |
Isis Pharmaceuticals, Inc. |
Modification of MyD88 splicing using modified oligonucleotides
|
|
JP2008531502A
(ja)
|
2005-02-22 |
2008-08-14 |
ザ レジェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
胃腸の炎症を処置する方法
|
|
EP1899467A2
(en)
|
2005-04-26 |
2008-03-19 |
Coley Pharmaceutical GmbH |
Modified oligoribonucleotide analogs with enhances immunostimulatory activity
|
|
KR20080065656A
(ko)
|
2005-10-12 |
2008-07-14 |
캔써 리서치 테크놀로지 리미티드 |
면역질환을 치료하기 위한 방법 및 조성물
|
|
CN101287742B
(zh)
|
2005-10-12 |
2016-01-06 |
艾德拉药物股份有限公司 |
基于变异应答调制Toll样受体的免疫调节寡核苷酸(IRO)化合物
|
|
WO2007059041A2
(en)
|
2005-11-11 |
2007-05-24 |
Pfizer, Inc. |
Combinations and methods of using an immunomodulatory oligodeoxynucleotide
|
|
ES2536103T3
(es)
|
2005-11-25 |
2015-05-20 |
Zoetis Belgium S.A. |
Oligorribonucleótidos inmunoestimuladores
|
|
DE112006003704A5
(de)
|
2005-11-25 |
2008-10-23 |
Mologen Ag |
DNA-Konstrukte zur spezifischen Hemmung der Genexpression durch RNA-Interferenz
|
|
JP2009525048A
(ja)
|
2006-02-01 |
2009-07-09 |
ザ ジョンズ ホプキンス ユニバーシティー |
腫瘍性障害または感染症に対する免疫学的予防法または免疫療法のためのポリペプチド−核酸複合体
|
|
PT2027266E
(pt)
*
|
2006-05-11 |
2011-03-14 |
Mologen Ag |
Multímero para a imunoestimulação
|
|
US20100130593A1
(en)
|
2006-06-13 |
2010-05-27 |
Bayhill Therapeutics, Inc. |
Methods and immune modulator nucleic acid compositions for preventing and treating disease
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
KR101378872B1
(ko)
|
2006-09-26 |
2014-04-11 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
합성 애주번트를 함유하는 백신 조성물
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EP2333091B1
(en)
|
2007-05-29 |
2017-06-21 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
BRPI0813626A2
(pt)
|
2007-07-27 |
2014-12-23 |
Immatics Biotechnologies Gmbh |
Epitopos imunogênicos para a imunoterapia
|
|
WO2009035554A2
(en)
|
2007-09-07 |
2009-03-19 |
University Of Florida Research Foundation, Inc. |
Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem
|
|
KR20100068422A
(ko)
|
2007-10-09 |
2010-06-23 |
콜리 파마슈티칼 게엠베하 |
변경된 당 잔기를 함유하는 면역자극성 올리고뉴클레오티드 유사체
|
|
EP2058397A1
(de)
|
2007-11-07 |
2009-05-13 |
Mologen AG |
Multimeres Assemblat zur Immunstimulation
|
|
JP5359883B2
(ja)
|
2007-11-28 |
2013-12-04 |
東レ株式会社 |
肝炎の治療剤又は予防剤
|
|
WO2009069447A1
(ja)
|
2007-11-28 |
2009-06-04 |
Toray Industries, Inc. |
インフルエンザワクチン用のアジュバント及びインフルエンザワクチン
|
|
WO2010039137A1
(en)
|
2008-10-02 |
2010-04-08 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
EP2246433A1
(de)
|
2009-04-30 |
2010-11-03 |
Mologen AG |
Concatemere zur Immunmodulation
|
|
KR20130063493A
(ko)
|
2010-03-26 |
2013-06-14 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
Ｈｉｖ 백신
|
|
GB201021873D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
DNA expression construct
|
|
GB201021867D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
Non-coding immunomodulatory DNA construct
|
|
JP5761707B2
(ja)
|
2011-02-02 |
2015-08-12 |
国立研究開発法人産業技術総合研究所 |
高効率細胞融合法
|
|
EP2744830A4
(en)
*
|
2012-06-21 |
2015-06-17 |
Compugen Ltd |
LSR ANTIBODIES AND USES THEREOF FOR THE TREATMENT OF CANCER
|
|
GB2514591A
(en)
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
GB2523187A
(en)
|
2014-02-18 |
2015-08-19 |
Mologen Ag |
Covalently closed non-coding immunomodulatory DNA construct
|
|
LU92821B1
(en)
*
|
2015-09-09 |
2017-03-20 |
Mologen Ag |
Combination comprising immunostimulatory oligonucleotides
|
|
GB2542425A
(en)
|
2015-09-21 |
2017-03-22 |
Mologen Ag |
Means for the treatment of HIV
|
|
EP3392345A1
(en)
|
2017-04-22 |
2018-10-24 |
Mologen AG |
Biomarker for small cell lung cancer therapy
|
|
EP3684470A1
(en)
|
2017-08-31 |
2020-07-29 |
Mologen AG |
Tlr-9 agonists for modulation of tumor microenvironment
|